{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:00:07Z","timestamp":1769608807931,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Arterial calcification represents a major burden in chronic kidney disease (CKD) and is an independent risk factor for cardiovascular diseases (CVD). Rodent models are essential for preclinical research on arterial calcification mechanisms and potential therapeutic interventions, permitting longitudinal analysis of disease progression, which is ethically unfeasible in humans. In this study, we specifically focused on rat models as representative rodent models, given their well-established use in cardiovascular research. Through systematic literature screening, we identified 470 studies employing rat models to investigate arterial calcification, with these models designed to simulate various pathological conditions. Our analysis revealed that arterial calcification was predominantly induced through kidney impairment, vitamin D overload, or mechanical and chemical vessel damage. Female rats were significantly underrepresented across studies, highlighting a considerable sex bias in experimental design. Particular emphasis was given to CKD-associated arterial calcification models, which accounted for about 60% of the identified studies. A meta-analysis of 67 CKD-related studies identified several significant factors influencing arterial calcification. Dietary phosphate concentration, male sex, and the use of Sprague-Dawley rats were associated with enhanced arterial calcification development. Nephrectomy-based approaches demonstrated superior efficacy and reliability in arterial calcification induction compared to adenine-based models. However, the analysis was limited by substantial heterogeneity across studies, potential publication bias, and inconsistent reporting of experimental parameters.<\/jats:p>\n                  <jats:p>These findings underscore the critical need for standardized reporting of experimental procedures and results to enhance the applicability of animal studies in meta-analyses and improve their translational value.<\/jats:p>","DOI":"10.1186\/s12872-025-05471-4","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:27:40Z","timestamp":1769513260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rat models for arterial calcification associated with chronic kidney disease: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Nicolas","family":"Hense","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melina","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"Marx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Kaesler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Goettsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"5471_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fcvm.2018.00027","volume":"5","author":"L Hortells","year":"2018","unstructured":"Hortells L, Sur S, St Hilaire C. Cell phenotype transitions in cardiovascular calcification. Front Cardiovasc Med. 2018;5:27. https:\/\/doi.org\/10.3389\/fcvm.2018.00027.","journal-title":"Front Cardiovasc Med"},{"key":"5471_CR2","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.120.050545","volume":"143","author":"AW Peng","year":"2021","unstructured":"Peng AW, Dardari ZA, Blumenthal RS, Dzaye O, Obisesan OH, Iftekhar Uddin SM, Nasir K, Blankstein R, Budoff MJ, Bodtker Mortensen M, et al. Very high coronary artery calcium (>\/=1000) and association with cardiovascular disease Events, Non-Cardiovascular disease Outcomes, and mortality: results from MESA. Circulation. 2021;143:1571\u201383. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050545.","journal-title":"Circulation"},{"key":"5471_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s43044-025-00608-4","volume":"77","author":"K Rezaie-Kalamtari","year":"2025","unstructured":"Rezaie-Kalamtari K, Norouzi Z, Salmanipour A, Mehrali H. Updates on CAD risk assessment: using the coronary artery calcium score in combination with traditional risk factors. Egypt Heart J. 2025;77:14. https:\/\/doi.org\/10.1186\/s43044-025-00608-4.","journal-title":"Egypt Heart J"},{"key":"5471_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/HCO.0000000000001185","volume":"40","author":"AC Razavi","year":"2025","unstructured":"Razavi AC, Whelton SP, Blumenthal RS, Blaha MJ, Dzaye O. Beyond the Agatston calcium score: role of calcium density and other calcified plaque markers for cardiovascular disease prediction. Curr Opin Cardiol. 2025;40:56\u201362. https:\/\/doi.org\/10.1097\/HCO.0000000000001185.","journal-title":"Curr Opin Cardiol"},{"key":"5471_CR5","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","volume":"117","author":"LL Demer","year":"2008","unstructured":"Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation. 2008;117:2938\u201348. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.743161.","journal-title":"Circulation"},{"key":"5471_CR6","doi-asserted-by":"publisher","first-page":"e000481","DOI":"10.1161\/JAHA.113.000481","volume":"2","author":"M Rogers","year":"2013","unstructured":"Rogers M, Goettsch C, Aikawa E. Medial and intimal calcification in chronic kidney disease: stressing the contributions. J Am Heart Assoc. 2013;2:e000481. https:\/\/doi.org\/10.1161\/JAHA.113.000481.","journal-title":"J Am Heart Assoc"},{"key":"5471_CR7","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1053\/j.ajkd.2004.07.022","volume":"44","author":"D Russo","year":"2004","unstructured":"Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE. Coronary artery calcification in patients with CRF not undergoing Dialysis. Am J Kidney Dis. 2004;44:1024\u201330. https:\/\/doi.org\/10.1053\/j.ajkd.2004.07.022.","journal-title":"Am J Kidney Dis"},{"key":"5471_CR8","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1681\/ASN.2022010080","volume":"33","author":"HR Yun","year":"2022","unstructured":"Yun HR, Joo YS, Kim HW, Park JT, Chang TI, Son NH, Yoo TH, Kang SW, Sung S, Lee KB, et al. Coronary artery calcification score and the progression of chronic kidney disease. J Am Soc Nephrol. 2022;33:1590\u2013601. https:\/\/doi.org\/10.1681\/ASN.2022010080.","journal-title":"J Am Soc Nephrol"},{"key":"5471_CR9","doi-asserted-by":"publisher","first-page":"e019300","DOI":"10.1161\/JAHA.120.019300","volume":"10","author":"S Park","year":"2021","unstructured":"Park S, Cho NJ, Heo NH, Rhee EJ, Gil H, Lee EY. Vascular calcification as a novel risk factor for kidney function deterioration in the nonelderly. J Am Heart Assoc. 2021;10:e019300. https:\/\/doi.org\/10.1161\/JAHA.120.019300.","journal-title":"J Am Heart Assoc"},{"key":"5471_CR10","doi-asserted-by":"publisher","unstructured":"Pan W, Jie W, Huang H. Vascular calcification: Molecular mechanisms and therapeutic interventions. MedComm (2020). 2023;4:e200. https:\/\/doi.org\/10.1002\/mco2.200.","DOI":"10.1002\/mco2.200"},{"key":"5471_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1139\/cjpp-2023-0206","volume":"102","author":"M Parikh","year":"2024","unstructured":"Parikh M, Pierce GN. Considerations for choosing an optimal animal model of cardiovascular disease. Can J Physiol Pharmacol. 2024;102:75\u201385. https:\/\/doi.org\/10.1139\/cjpp-2023-0206.","journal-title":"Can J Physiol Pharmacol"},{"key":"5471_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"5471_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting Meta-Analyses in R with the metafor package. J Stat Softw. 2010;36:1\u201348. https:\/\/doi.org\/10.18637\/jss.v036.i03.","journal-title":"J Stat Softw"},{"key":"5471_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43. https:\/\/doi.org\/10.1186\/1471-2288-14-43.","journal-title":"BMC Med Res Methodol"},{"key":"5471_CR15","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1042\/CS20210259","volume":"135","author":"L Feng","year":"2021","unstructured":"Feng L, Que D, Li Z, Zhong X, Yan J, Wei J, Zhang X, Yang P, Ou C, Chen M. Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling. Clin Sci (Lond). 2021;135:2483\u2013502. https:\/\/doi.org\/10.1042\/CS20210259.","journal-title":"Clin Sci (Lond)"},{"key":"5471_CR16","doi-asserted-by":"publisher","first-page":"e10837","DOI":"10.1002\/jbm4.10837","volume":"7","author":"A Biruete","year":"2023","unstructured":"Biruete A, Chen NX, Metzger CE, Srinivasan S, O\u2019Neill K, Fallen PB, Fonseca A, Wilson HE, de Loor H, Evenepoel P, et al. The dietary fiber inulin slows progression of chronic kidney Disease-Mineral bone disorder (CKD-MBD) in a rat model of CKD. JBMR Plus. 2023;7:e10837. https:\/\/doi.org\/10.1002\/jbm4.10837.","journal-title":"JBMR Plus"},{"key":"5471_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/ATVBAHA.119.313414","volume":"40","author":"X Zhang","year":"2020","unstructured":"Zhang X, Li Y, Yang P, Liu X, Lu L, Chen Y, Zhong X, Li Z, Liu H, Ou C, et al. Trimethylamine-N-Oxide promotes vascular calcification through activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) inflammasome and NF-kappaB (Nuclear factor kappaB) signals. Arterioscler Thromb Vasc Biol. 2020;40:751\u201365. https:\/\/doi.org\/10.1161\/ATVBAHA.119.313414.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5471_CR18","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1093\/ndt\/gfac162","volume":"37","author":"A Biruete","year":"2022","unstructured":"Biruete A, Metzger CE, Chen NX, Swallow EA, Vrabec C, Clinkenbeard EL, Stacy AJ, Srinivasan S, O\u2019Neill K, Avin KG, et al. Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD. Nephrol Dial Transpl. 2022;37:1857\u201367. https:\/\/doi.org\/10.1093\/ndt\/gfac162.","journal-title":"Nephrol Dial Transpl"},{"key":"5471_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.freeradbiomed.2024.06.010","volume":"222","author":"Z Chen","year":"2024","unstructured":"Chen Z, Li X, Sun X, Xiao S, Chen T, Ren L, Liu N. STING1-accelerated vascular smooth muscle cell senescence-associated vascular calcification in diabetes is ameliorated by oleoylethanolamide via improved mitochondrial DNA oxidative damage. Free Radic Biol Med. 2024;222:437\u201355. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.06.010.","journal-title":"Free Radic Biol Med"},{"key":"5471_CR20","doi-asserted-by":"publisher","first-page":"e10600","DOI":"10.1002\/jbm4.10600","volume":"6","author":"JG Damrath","year":"2022","unstructured":"Damrath JG, Chen NX, Metzger CE, Srinivasan S, O\u2019Neill K, Biruete A, Avin KG, Wallace JM, Allen MR, Moe SM. Non-Additive effects of combined NOX1\/4 Inhibition and calcimimetic treatment on a rat model of chronic kidney Disease-Mineral and bone disorder (CKD-MBD). JBMR Plus. 2022;6:e10600. https:\/\/doi.org\/10.1002\/jbm4.10600.","journal-title":"JBMR Plus"},{"key":"5471_CR21","doi-asserted-by":"publisher","first-page":"e22504","DOI":"10.1096\/fj.202200353RRR","volume":"36","author":"W Jiang","year":"2022","unstructured":"Jiang W, Ruan W, Wang Z. Dendrobium officinale polysaccharide inhibits vascular calcification via anti-inflammatory and anti-apoptotic effects in chronic kidney disease. FASEB J. 2022;36:e22504. https:\/\/doi.org\/10.1096\/fj.202200353RRR.","journal-title":"FASEB J"},{"key":"5471_CR22","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.18632\/aging.205492","volume":"16","author":"Y Li","year":"2024","unstructured":"Li Y, Cheng M, Jin J, Zhang D, Zhang S, Bai Y, Xu J. Interaction of Sp1 and Setd8 promotes vascular smooth muscle cells apoptosis by activating Mark4 in vascular calcification. Aging. 2024;16:2438\u201356. https:\/\/doi.org\/10.18632\/aging.205492.","journal-title":"Aging"},{"key":"5471_CR23","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/cvr\/cvac162","volume":"119","author":"ME Turner","year":"2023","unstructured":"Turner ME, Rowsell TS, Lansing AP, Jeronimo PS, Lee LH, Svajger BA, Zelt JGE, Forster CM, Petkovich MP, Holden RM, et al. Vascular calcification maladaptively participates in acute phosphate homeostasis. Cardiovasc Res. 2023;119:1077\u201391. https:\/\/doi.org\/10.1093\/cvr\/cvac162.","journal-title":"Cardiovasc Res"},{"key":"5471_CR24","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.52586\/5008","volume":"26","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhou X, Huang Z, Fan X, Tan X, Lu C, Yang J. Aldosterone is a possible new stimulating factor for promoting vascular calcification. Front Biosci (Landmark Ed). 2021;26:1052\u201363. https:\/\/doi.org\/10.52586\/5008.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"5471_CR25","doi-asserted-by":"publisher","first-page":"100535","DOI":"10.1016\/j.xkme.2022.100535","volume":"4","author":"C Hockham","year":"2022","unstructured":"Hockham C, Schanschieff F, Woodward M. Sex differences in CKD-Associated mortality from 1990 to 2019: data from the global burden of disease study. Kidney Med. 2022;4:100535. https:\/\/doi.org\/10.1016\/j.xkme.2022.100535.","journal-title":"Kidney Med"},{"key":"5471_CR26","doi-asserted-by":"publisher","first-page":"117269","DOI":"10.1016\/j.atherosclerosis.2023.117269","volume":"384","author":"A Rajendran","year":"2023","unstructured":"Rajendran A, Minhas AS, Kazzi B, Varma B, Choi E, Thakkar A, Michos ED. Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women. Atherosclerosis. 2023;384:117269. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117269.","journal-title":"Atherosclerosis"},{"key":"5471_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2018030296","volume":"30","author":"AC Ricardo","year":"2019","unstructured":"Ricardo AC, Yang W, Sha D, Appel LJ, Chen J, Krousel-Wood M, Manoharan A, Steigerwalt S, Wright J, Rahman M, et al. Sex-Related disparities in CKD progression. J Am Soc Nephrol. 2019;30:137\u201346. https:\/\/doi.org\/10.1681\/ASN.2018030296.","journal-title":"J Am Soc Nephrol"},{"key":"5471_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/vhrm.s4822","volume":"5","author":"RJ Rennenberg","year":"2009","unstructured":"Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW, Kroon AA. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag. 2009;5:185\u201397. https:\/\/doi.org\/10.2147\/vhrm.s4822.","journal-title":"Vasc Health Risk Manag"},{"key":"5471_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jacl.2020.12.005","volume":"15","author":"CE Orringer","year":"2021","unstructured":"Orringer CE, Blaha MJ, Blankstein R, Budoff MJ, Goldberg RB, Gill EA, Maki KC, Mehta L, Jacobson TA. The National lipid association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction. J Clin Lipidol. 2021;15:33\u201360. https:\/\/doi.org\/10.1016\/j.jacl.2020.12.005.","journal-title":"J Clin Lipidol"},{"key":"5471_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11886-020-1267-9","volume":"22","author":"A Bigeh","year":"2020","unstructured":"Bigeh A, Shekar C, Gulati M. Sex differences in coronary artery calcium and Long-term CV mortality. Curr Cardiol Rep. 2020;22:21. https:\/\/doi.org\/10.1007\/s11886-020-1267-9.","journal-title":"Curr Cardiol Rep"},{"key":"5471_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1161\/CIRCRESAHA.116.309306","volume":"120","author":"L Simard","year":"2017","unstructured":"Simard L, Cote N, Dagenais F, Mathieu P, Couture C, Trahan S, Bosse Y, Mohammadi S, Page S, Joubert P, et al. Sex-Related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis: is valvular fibrosis the explanation? Circ Res. 2017;120:681\u201391. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309306.","journal-title":"Circ Res"},{"key":"5471_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41581-023-00784-z","volume":"20","author":"NC Chesnaye","year":"2024","unstructured":"Chesnaye NC, Carrero JJ, Hecking M, Jager KJ. Differences in the epidemiology, management and outcomes of kidney disease in men and women. Nat Rev Nephrol. 2024;20:7\u201320. https:\/\/doi.org\/10.1038\/s41581-023-00784-z.","journal-title":"Nat Rev Nephrol"},{"key":"5471_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12882-018-0937-y","volume":"19","author":"J Neugarten","year":"2018","unstructured":"Neugarten J, Golestaneh L, Kolhe NV. Sex differences in acute kidney injury requiring Dialysis. BMC Nephrol. 2018;19:131. https:\/\/doi.org\/10.1186\/s12882-018-0937-y.","journal-title":"BMC Nephrol"},{"key":"5471_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31\u20138. https:\/\/doi.org\/10.1038\/sj.ki.5002009.","journal-title":"Kidney Int"},{"key":"5471_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1440-1797.2012.01618.x","volume":"17","author":"ND Toussaint","year":"2012","unstructured":"Toussaint ND, Pedagogos E, Tan SJ, Badve SV, Hawley CM, Perkovic V, Elder GJ. Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk. Nephrol (Carlton). 2012;17:433\u201344. https:\/\/doi.org\/10.1111\/j.1440-1797.2012.01618.x.","journal-title":"Nephrol (Carlton)"},{"key":"5471_CR36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2215\/CJN.06080809","volume":"5","author":"K Kalantar-Zadeh","year":"2010","unstructured":"Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:519\u201330. https:\/\/doi.org\/10.2215\/CJN.06080809.","journal-title":"Clin J Am Soc Nephrol"},{"key":"5471_CR37","doi-asserted-by":"publisher","unstructured":"Rose SD, Strombom AJ. A Plant-Based diet prevents and treats chronic kidney disease. JOJ Urol Nephrol. 2019;6. https:\/\/doi.org\/10.19080\/JOJUN.2019.06.555687.","DOI":"10.19080\/JOJUN.2019.06.555687"},{"key":"5471_CR38","doi-asserted-by":"publisher","first-page":"597605","DOI":"10.1155\/2012\/597605","volume":"2012","author":"E Gonzalez-Parra","year":"2012","unstructured":"Gonzalez-Parra E, Gracia-Iguacel C, Egido J, Ortiz A. Phosphorus and nutrition in chronic kidney disease. Int J Nephrol. 2012;2012:597605. https:\/\/doi.org\/10.1155\/2012\/597605.","journal-title":"Int J Nephrol"},{"key":"5471_CR39","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s11357-023-00775-9","volume":"45","author":"J Lee","year":"2023","unstructured":"Lee J, Purello C, Booth SL, Bennett B, Wiley CD, Korstanje R. Chow diet in mouse aging studies: nothing regular about it. Geroscience. 2023;45:2079\u201384. https:\/\/doi.org\/10.1007\/s11357-023-00775-9.","journal-title":"Geroscience"},{"key":"5471_CR40","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1002\/jbmr.1994","volume":"28","author":"R Kramann","year":"2013","unstructured":"Kramann R, Kunter U, Brandenburg VM, Leisten I, Ehling J, Klinkhammer BM, Knuchel R, Floege J, Schneider RK. Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease. J Bone Min Res. 2013;28:2523\u201334. https:\/\/doi.org\/10.1002\/jbmr.1994.","journal-title":"J Bone Min Res"},{"key":"5471_CR41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2369-15-69","volume":"15","author":"GO Ferrari","year":"2014","unstructured":"Ferrari GO, Ferreira JC, Cavallari RT, Neves KR, dos Reis LM, Dominguez WV, Oliveira EC, Graciolli FG, Passlick-Deetjen J, Jorgetti V, et al. Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5\/6 nephrectomy and adenine models. BMC Nephrol. 2014;15:69. https:\/\/doi.org\/10.1186\/1471-2369-15-69.","journal-title":"BMC Nephrol"},{"key":"5471_CR42","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1111\/bph.15193","volume":"177","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. Br J Pharmacol. 2020;177:3617\u201324. https:\/\/doi.org\/10.1111\/bph.15193.","journal-title":"Br J Pharmacol"},{"key":"5471_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/0023677217724823","volume":"52","author":"AJ Smith","year":"2018","unstructured":"Smith AJ, Clutton RE, Lilley E, Hansen KEA, Brattelid T. PREPARE: guidelines for planning animal research and testing. Lab Anim. 2018;52:135\u201341. https:\/\/doi.org\/10.1177\/0023677217724823.","journal-title":"Lab Anim"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05471-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05471-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05471-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:05:06Z","timestamp":1769558706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-025-05471-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5471"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05471-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}